Clinical Trial

Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

Recruiting
View on ClinicalTrials.gov →
Summary
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-09-28; most recent amendment 2026-07-02.
Status change: Active, Not Recruiting → Recruiting 2024-07-16
Status change: Recruiting → Active, Not Recruiting 2023-12-05
Trial Details
NCT Number NCT05562323
Lead Sponsor Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborators: IrsiCaixa, BCN Checkpoint
Conditions Monkeypox
Enrollment 100 participants
Start Date 2022-09-14
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-07